Navigation Links
Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
Date:2/4/2008

Tryton's revolutionary Side Branch Stent obtains CE Mark approval based on

unprecedented results in the Tryton 1 (First-in-Man Study) with No

Side-Branch Restenosis in 30 patients.

NEWTON, Mass., Feb. 4 /PRNewswire/ -- Tryton Medical, Inc., the leading developer of stents designed for the definitive treatment bifurcation lesions announced that the company has received CE Mark approval for its Side Branch Stent. The Tryton Side-Branch Stent is a high performance cobalt chromium balloon-expandable coronary stent specifically developed for the complete treatment of the entire spectrum of coronary artery bifurcation disease. Approximately 540,000 annual procedures are performed to address bifurcation lesions, accounting for 20% of all coronary lesions treated. With the exception of Tryton's stent, no dedicated solution exists today that fully addresses these lesions.

The results of the Tryton 1 (First-In-Man) Study were presented by Prof. Patrick Serruys (Erasmus University/Thoraxcenter, Rotterdam NL) and Ralf Mller, M.D. (Helios Heart Centrum, Siegburg DE). When the Tryton cobalt chromium Bare Metal Stent was used with a standard drug eluting stent (Cypher Select, Taxus or Xience V), no side branch restenosis was observed in the 30 patients treated. The initial core laboratory quantitative analysis reported a late loss of 0.27 +/- 0.42 mm in the side branch and 0.12 +/- 0.47 mm in the main vessel. "This technology has the capacity to redefine the treatment of bifurcation lesions and resolve a frequent dilemma of the interventional cardiologist," said Professor Patrick W. J. C. Serruys, M.D., Head of the Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

"CE Mark will allow us to bring this important technology to market in Europe. A market launch is planned for May in conjunction with EuroPCR 2008," stated H. Richard Davis, CTO, Tryton Medical, Inc.

Every
'/>"/>

SOURCE Tryton Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
2. Medical University of South Carolina Opens State-of-the-Art Facility
3. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Rosetta Genomics Establishes Medical Advisory Board
5. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
6. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
7. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
11. Sales of Stem Cell Products Expected to Reach $87 Million in 2008, Leading Medical Industry Analyst Says

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 Reportlinker.com announces... its catalogue: ,, Brazil Bioethanol Market An...portlinker.com/p0165503/Brazil-Bioethanol-Market-A...ioethanol Market Analysis and Forecasts to 2013 ,...nalysis and forecasts of the global bioethanol mar...
(Date:11/24/2009)...bassador to also Visit Detroit , ...id Appia, French Ambassador for International Inve...ce Agency, , , , ,What: Ambassador Appia is avail...ness initiatives adopted by France to further deve...or innovation and development., , ,When: Available...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-First...ay announced that it has received notice from,the ...common stock will be,suspended as of November 30, ...rities and Exchange Commission, which will remove ...ss the company files an appeal to the Nasdaq,Listi...
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals ...e (PTO) has allowed the patent application for,its..., NOD technology is a highly efficient appr...adhesive nano-particles to enable oral delivery of...echnology is a platform technology,that can be app...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...rt(R)-Based Test to Assess Genetic Risk of Thrombo...ys Associated with Batch Processing, SUNNYVALE, C...irstCall/,-- Cepheid (Nasdaq: CPHD ) and Instrume...stics company, today announced the release of the ... CE IVD Mark product under the,European Directive ...
...Feb. 25 Newly published data by Dr. J.,Barthelow ...y to cause,diabetes in children with a strong fami... papers provided proof that vaccines cause diabete...eir benefit in the general,population. New data in...ith a strong family history of diabetes. For examp...
...Feb. 25 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX...ief Medical,Officer and Executive Vice President o...d of Directors. In connection with Dr. Rowinsky,s ...rd from six to seven directors., "We are delighte...ings,tremendous knowledge and expertise within the...
Other Biology Technology:Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 2Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 3Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 4Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market 5Eric K. Rowinsky Joins ADVENTRX Board of Directors 2Eric K. Rowinsky Joins ADVENTRX Board of Directors 3Eric K. Rowinsky Joins ADVENTRX Board of Directors 4
(Date:11/26/2009)...ht European countries has shown that closing schoo...could have a significant role in reducing illness ...ss journal BMC Infectious Diseases compared oppo...s/holidays, finding that they were reduced when sc...twerp University, Belgium, led a team of European ...
(Date:11/25/2009)... in the stomach, may be used to boost resistance t..., Yale School of Medicine researchers report in a ...of Neuroscience . , Parkinson,s disease is cause... of the midbrain known as the substantia nigra, wh...ed production of dopamine in late-stage Parkinson,...
(Date:11/25/2009)...me, the heart pumps some 250 million liters of blo...muscle fibers of the heart have to be extremely du...ottbauer, vice chair of the Department of Medicine...Prof. Dr. H. A. Katus), has discovered a protein t...st muscular unit, the sarcomere. In cooperation wi...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 1CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 3IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 1IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 2Involving family in medical rounds benefits both family and medical team 62042 1Involving family in medical rounds benefits both family and medical team 62042 2Involving family in medical rounds benefits both family and medical team 62042 3Involving family in medical rounds benefits both family and medical team 62042 4
...dies of the birth and incorporation of neurons int...dult neurogenesispromise intriguing insights into ...he causes of depression and other psychiatric diso...ory Press ( www.cshlpress.com ) helps to define th... ( http://www.cshlpress.com/link/adultneuro.htm ) ...
... of world-leading scientists including those who ...rown at a parasitic worm less than 1mm long. , T...attacks potato crops all over the world and is par...e the potato is a subsistence crop. A 1.7 million ...quence its DNA, hopes to shed light on the mechani...
...ree of Life for flowering plants has been revealed...hese plants to date, report scientists from The Un...ida. , The scientists, publishing two papers in P...s week online, found that the two largest groups o...latives) and eudicots (including sunflowers and to...
Other Biology News:New book defines promising young field of adult neurogenesis 2New research to decode the genetic secrets of prolific potato pest 2Tree of life for flowering plants reveals relationships among major groups 2
...a complete assay system for the measurement of 1,2...asma. The assay incorporates the same award-winnin...IA followed by quantitation by convenient enzymeim...nts, no organic or solvent waste disposal is requi...
Rabbit Anti-Nck alpha Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Rabbit Anti-Human ABCD4 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: